The third-place slot marked another return to form. Novo Nordisk’s Wegovy reclaimed the seat it held in December, backed by ...
Japan's Ono Pharmaceutical is handing over $280 million upfront to acquire Ionis Pharmaceuticals’ phase 2-stage antisense ...
Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback